Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bovine type I collagen is a naturally occurring extracellular matrix protein derived from cows. It is the most abundant form of collagen in mammals and is found in connective tissues such as tendons, skin, ligaments, bone, and blood vessels. Bovine type I collagen plays a vital role in cell growth, differentiation, attachment, and migration. It is widely used for wound healing due to its biocompatibility and low immunogenicity. In clinical settings and research applications, it serves as a scaffold for tissue engineering and regenerative medicine. Pharmaceutical products based on this protein are used to treat wounds and support bone or joint health[1][3][4]. The mechanism of action involves providing structural support to tissues by forming the primary organic component of the extracellular matrix; it also promotes cellular attachment and proliferation[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bovine type I collagen.